Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Kim (Los Angeles, United States of America). Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF. 1957

Member's Comments

No comment yet.

Related content which might interest you: Assessment of survival in patients with idiopathic pulmonary fibrosis (IPF) using quantitative HRCT indexes Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00074-2016; 10.1183/23120541.00074-2016 Year: 2017 Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Voxelwise lung pattern transition scores on HRCT images and their association with symptoms in patients with idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Male gender and fibrosis score on high-resolution computed tomography are independent poor prognostic factors of survival in patients with rheumatoid arthritis-related interstitial lung disease. Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017 Year: 2018 Correlations of quantitative HRCT score in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016 Year: 2017 Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs Source: International Congress 2016 – Clinical aspects of ILD Year: 2016